Skip to main contentSkip to navigation
Sirius Investors

HTSUY Stock: Hisamitsu Pharmaceutical Co., Inc. Stock Price, Analysis & Insights

Get live HTSUY stock price $2.94, comprehensive Hisamitsu Pharmaceutical Co., Inc. stock analysis, charts, news, and expert forecast. Real-time HTSUY stock data and investment insights.

2.94
0.00%Today
HTSUYHisamitsu Pharmaceutical Co., Inc. • Other OTC • Healthcare
Market Cap
839.03M
Volume
0
52W High
9.42
52W Low
2.94

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Hisamitsu Pharmaceutical Co., Inc. is a company dedicated to the entire lifecycle of healthcare products, from initial research and development to manufacturing and global distribution of pharmaceuticals and related health solutions. It is particular...

Company Information

CEO
Kazuhide Nakatomi
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
2769

Contact Information

Address
408 Tashirodaikan-machi
Country
JP

Investment Analysis & Business Insights

Healthcare
Medical - Pharmaceuticals

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: 0.04) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Hisamitsu Pharmaceutical Co., Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Hisamitsu Pharmaceutical Co., Inc.
  • Investors should consider how Hisamitsu Pharmaceutical Co., Inc. fits within their overall portfolio allocation

Market Cap

839.03M

Beta

0.04

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.